![Card image cap](https://i0.wp.com/docmode.org/wp-content/uploads/2021/12/COVID-VACCINE.jpg?fit=1000%2C744&ssl=1)
US FDA authorises second booster dose of Covid vaccine
The US FDA has authorised a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people and certain immunocompromised individuals. The US drug regulator previously authorised a single booster dose for certain immunocompromised individuals following completion of a three-dose primary vaccination series. This action will now make a second booster dose of these vaccines available to other populations at higher risk for severe disease, hospitalisation and death. Emerging evidence suggests that a second booster dose of an mRNA COVID-19 vaccine improves protection against severe COVID-19 and is not associated with new safety concerns.